What Happened?
Columbus, OH-based Sermonix-Pharmaceuticals Appointed David Portman as Chief Executive Officer
About the Company
Sermonix Pharmaceuticals is an Ohio LLC privately held biotechnology company with a targeted focus towards bringing female-specific oncology products through proof of concept, preclinical, and clinical development with a clear regulatory pathway in place. Sermonix was founded in late 2014 by David Portman, MD, a leading clinical researcher and expert in women`s health, menopause and selective estrogen receptor modulators, or SERM therapy.
About the Person
David Portman is Chief Executive Officer at Sermonix Pharmaceuticals. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile